The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
VIDEO: There's more to the biotech sector than the Covid-19 vaccine. International Biotech Trust ...
VIDEO: Are there still opportunities in the biotech sector now the Covid-19 vaccine roll out is u...
The UK's biggest pharmaceutical companies are leading the fight against Covid-19, but underwhelmi...
Ailsa Craig, co-manager of the International Biotechnology Trust, says trading in and out of stoc...
VIDEO: Oncology is just one burgeoning area in biotech, says International Biotechnology Trust's ...
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
As Burberry's share price continues to fall, here are the 10 funds with the largest exposure to t...
Headline CPI figure likely to remain at 2%, but economists are more focused on core and services ...
Reports of 60/40's death have been greatly exaggerated, but some now say 40% fixed income allocat...
Burberry's shares dropped over 16% after expectations that its annual profits would be weaker tha...
After June's initial rate cut, here's what analysts and economists expect the European Central Ba...